Prognostic indicators for the diagnosis of multiple myeloma.
Treatment regimens for multiple myeloma are evolving because of new advances in both pharmacotherapy and transplantation strategies. The Multiple Myeloma Research Foundation (MMRF) has gathered the top thought leaders in myeloma research to prepare an engaging, interactive series of case studies in multiple myeloma, which are available online at www. multiplemyeloma.org and are published on a regular basis in ONCOLOGY. For more information about the interactive series, see the MMRF ad on page 677.
Greipp
Philip
P
Hematology Research, Mayo Clinic Rochester, Minnesota, USA.
D002118:Calcium / Q000097:blood; D020732:Cytogenetic Analysis / Q000379:methods; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000235:genetics; D010950:Plasma Cells / Q000473:pathology; D011379:Prognosis; D001613:beta 2-Microglobulin / Q000032:analysis
D001613:beta 2-Microglobulin; D002118:Calcium